Zhengying Pan

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Breast Cancer Cells

Tyrosine Kinase

Induced Apoptosis

Top Venues

Journal of medicinal chemistry

Chemical communications (Cambridge, England)

Bioconjugate chemistry

Journal of the American Chemical Society

This page only lists publications with an associated author ORCID identifier.

Publications

Danli Zhou, Yingying Zuo, Zhengying Pan
Discovery of Potent and Highly Selective Interleukin-2-Inducible T-Cell Kinase Degraders with In Vivo Activity. Journal of medicinal chemistry (2023)
Rui Chen, Ziyue Wang, Lihong Liu, Zhengying Pan
Discovery of novel photocaged ERK1/2 inhibitors as light-controlled anticancer agents. Chemical communications (Cambridge, England) 58 (31) (2022)
Zhenpeng Zhong, Liyang Shi, Tiancheng Fu, Jiajun Huang, Zhengying Pan
Discovery of Novel 7-Azaindole Derivatives as Selective Covalent Fibroblast Growth Factor Receptor 4 Inhibitors for the Treatment of Hepatocellular Carcinoma. Journal of medicinal chemistry 65 (10) (2022)
Gang Xue, Kun Wang, Danli Zhou, Hanbing Zhong, Zhengying Pan
Light-Induced Protein Degradation with Photocaged PROTACs. Journal of the American Chemical Society 141 (46) (2019)
Liyang Shi, Zhenpeng Zhong, Xitao Li, Yiqing Zhou, Zhengying Pan
Discovery of an Orally Available Janus Kinase 3 Selective Covalent Inhibitor. Journal of medicinal chemistry 62 (2) (2019)
Jiahui Chen, Xiafeng Wang, Fengli He, Zhengying Pan
Development of a Selective Labeling Probe for Bruton's Tyrosine Kinase Quantification in Live Cells. Bioconjugate chemistry 29 (5) (2018)